Drug
Solifenacin clinical trials
Also written Vesicare and YM905.
- studies test it
- 99
- open now
- 8
- in phase 3
- 24
- first study started
- 2003
Keep track of what changes. Save the solifenacin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Vesicare
- 49
Combined with it in one product
Studies by the year they started
98 studies that test it; most in 2010 (13)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 4 |
| 2006 | 5 |
| 2007 | 6 |
| 2008 | 8 |
| 2009 | 6 |
| 2010 | 13 |
| 2011 | 7 |
| 2012 | 12 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 13
- Phase 2
- 8
- Phase 3
- 24
- Phase 4
- 38
- No phase
- 15
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 49 · Other 50
Astellas Pharma Inc (26) · Astellas Pharma Europe B.V. (14) · Mansoura University (3) · Far Eastern Memorial Hospital (3) · Loyola University (3) · National Taiwan University Hospital (3) · University of Aarhus (2) · University of South Florida (2)
Often tested with
Tested in the same studies.
Mirabegron (19) · Tamsulosin (15) · Tolterodine (3) · Tadalafil (2) · EC905 (2) · Oxybutynin (2) · Estrogens (2) · Vitamin D (1)
Studies
Open first, then newest update. How each study uses solifenacin is read from its arms, and is right about nine times in ten.
Testing it · 99
- Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)RecruitingPhase 3University of AarhusNCT06551246Written as Solifenacin
- Melatonin and Solifenacin for Double-J Ureteral Stent SymptomsRecruitingPhase 2Beni-Suef UniversityNCT07617922Written as Solifenacin
- Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsRecruitingPhase 2University of ArkansasNCT01530373Written as solifenacin
- Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related SymptomsRecruitingPhase 3Bir HospitalNCT06803030Written as Solifenacin Succinate 5 mg
- The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled TrialNot yet recruitingPhase 3Far Eastern Memorial HospitalNCT07114640Written as Solifenacin 5 mg
- Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive BladderRecruitingPhase 4Mackay Memorial HospitalNCT06479720Written as Solifenacin with vaginal estrogen cream
- Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor OveractivityRecruitingPhase 4Mackay Memorial HospitalNCT06197295Written as Solifenacin with vaginal estrogen cream
- Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus SolifenacinRecruitingPhase 3Far Eastern Memorial HospitalNCT04023253Written as Solifenacin
- Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)Active, not recruitingPhase 4University of AarhusNCT06465576Written as Solifenacin
- Double j Stent Related SymptomsCompletedEarly Phase 1Kafrelsheikh UniversityNCT07447518Written as Solfenacin
- Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic BiomarkerCompletedNot applicableXing LiuNCT06489951Written as Solifenacin
- Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.CompletedPhase 4Liaquat National Hospital & Medical CollegeNCT07114848Written as solifenacin
- Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.CompletedPhase 4Astellas Pharma IncNCT01093534Written as solifenacin
- Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract SymptomsCompletedPhase 3Astellas Pharma Europe B.V.NCT01021332Written as tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
- Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract SymptomsCompletedPhase 3Astellas Pharma Europe B.V.NCT01018511Written as tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
- A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical ProstatectomyCompletedPhase 4Astellas Pharma IncNCT01371994Written as solifenacin succinate
- A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor OveractivityCompletedPhase 3Astellas Pharma Europe B.V.NCT01565694Written as Solifenacin succinate
- Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple SclerosisCompletedPhase 4Astellas Pharma IncNCT00629642Written as Solifenacin Succinate
- A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076CompletedPhase 3Astellas Pharma Europe B.V.NCT01655069Written as Solifenacin succinate suspension
- Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)CompletedPhase 4Astellas Pharma Korea, Inc.NCT01747577Written as Solifenacin Succinate
See all 99 studies that test solifenacin →
Given in every arm · 4 — solifenacin is usual care beside what is tested
- Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.CompletedPhase 4Astellas Pharma IncNCT02294396Written as Solifenacin tablet
- Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OABStatus unknownPhase 4Mansoura UniversityNCT05494567Written as solifenacin 10 mg
- Therapy of the Overactive Bladder SyndromeCompletedPhase 4Cantonal Hospital, FrauenfeldNCT01314781Written as solifenacin
- Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal WomenCompletedPhase 4Peking Union Medical College HospitalNCT01833663Written as Solifenacin Succinate Tablets
As the comparator · 23 — what is tested is compared with solifenacin
- Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-WetRecruitingNot applicableChildren's Hospital of Chongqing Medical UniversityNCT06201013Written as Solifenacin Succinate
- Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in WomenRecruitingPhase 4Mansoura UniversityNCT07473310Written as Oral Solifenacin succinate 5 mg
- Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National StudyRecruitingPhase 4Mansoura UniversityNCT07416968Written as Solifenacin 5mg
- Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive BladderRecruitingNot applicableYin PingNCT05798403Written as Solifenacin Succinate Tablets
- Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in FemalesCompletedNot applicableAin Shams UniversityNCT07312955Written as Solifenacin
- A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.CompletedPhase 3Astellas Pharma Europe Ltd.NCT01638000Written as Solifenacin succinate
- A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive BladderCompletedPhase 3Dong-A ST Co., Ltd.NCT05282069Written as Solifenacin 5mg
- Study of ONO-8577 in Patients With Overactive BladderCompletedPhase 2Ono Pharmaceutical Co. LtdNCT03106623Written as solifenacin succinate + mirabegron
- Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in ChildrenCompletedNot applicableXing LiuNCT05709990Written as Solifenacin Succinate 5 MG Oral Tablet [Vesicare]
- Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus Vesicare 5 mg FCT & Betmiga 50 mg Prolonged-Release Tablets (Astellas Pharma Europe B.V, the Netherlands / Astellas Pharma Europe B.V, the Netherlands)CompletedPhase 1Genuine Research Center, EgyptNCT05767632Written as Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
- Electroacupuncture and Solifenacin for Urgency-predominant Mixed Urinary IncontinenceStatus unknownNot applicableGuang'anmen Hospital of China Academy of Chinese Medical SciencesNCT03787654Written as Solifenacin
- Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive BladderStatus unknownPhase 4China Medical University HospitalNCT04909255Written as oxybutynin, tolterodine, solifenacin
- A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive BladderCompletedPhase 2Dong-A ST Co., Ltd.NCT03566134Written as Solifenacin 5mg
- Effect of Electroacupuncture Versus PFMT Plus Solifenacin for Mixed Urinary IncontinenceCompletedNot applicableGuang'anmen Hospital of China Academy of Chinese Medical SciencesNCT02047032Written as solifenacin
- A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary IncontinenceCompletedPhase 3AllerganNCT01767519Written as solifenacin
- Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder SyndromeStatus unknownPhase 4Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaNCT03468465Written as Solifenacin Succinate
- Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive BladderCompletedPhase 4Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshNCT03558919Written as Solifenacin Succinate 5 MG
- Anticholinergic vs. Botox Comparison StudyCompletedPhase 3NICHD Pelvic Floor Disorders NetworkNCT01166438Written as Solifenacin 5mg
- Efficacy and Safety of Gabapentin in Treating Overactive BladderCompletedPhase 2/3Michael E. ChuaNCT01486706Written as Solifenacin Succinate
- Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy StudyStatus unknownNot applicableGuang'anmen Hospital of China Academy of Chinese Medical SciencesNCT02452879Written as Solifenacin Succinate
Showing 20 of 23.
Codes
What other systems call solifenacin · ClinicalTrials.gg INT006592
- MeSH (NLM) D000069464Solifenacin SuccinateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) A8910SQJ1USOLIFENACINConfirmed FDA, NLM, Wikidata
- RxNorm 322167One source FDA
- Wikidata Q59575279solifenacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75284SolifenacinOne source FDA
- DrugBank DB01591One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069464 | Solifenacin Succinate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | A8910SQJ1U | SOLIFENACIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 322167 | — | One source FDA |
| Wikidata | Q59575279 | solifenacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75284 | Solifenacin | One source FDA |
| DrugBank | DB01591 | — | One source Wikidata |
Also registered as solifenacin succinate (UNII KKA5DLD701 · RxNorm 476588).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.